Expert Witness
Consultant Medical Oncologist Mb ChB, FRCP, PgCert, PhD
- Qualifications include
- FRCP
- Usual report turnaround
- 10–12 weeks
- Member of the European Thoracic Oncology Platform
- ETOP
- Instructed by
- Claimant & Defendant
Medico-legal
Medico-legal experience
Dr Escriu is registered with the Association of Personal Injury Lawyers (APIL), the National Crime Agency (NCA), and the UK Register of Expert Witnesses. Dr Escriu enjoys a full medico-legal practice instructed by both Claimant and Defendant law firms in personal injury and clinical negligence cases. Dr Escriu holds weekly medico-legal clinics in Manchester, but is happy to travel in order to conduct home and prison visits. He can produce reports within 10-12 weeks, sooner if required.
Specialisms
Areas of expertise
Profile
Professional background
Dr Escriu attained his PhD in cancer biology from the University of Cambridge. Since 2016, he has practised as a Consultant Medical Oncologist, with a subspecialty in thoracic oncology at the Clatterbridge Cancer Centre NHS Foundation Trust where he also leads the largest mutation-driven lung cancer clinic in the UK. In addition to his NHS responsibilities, he is a North West Clinical Cancer Research Network & Thoracic Oncology Lead and the Clinical Research Lead for Thoracic Oncology at the Clatterbridge Cancer Centre.
Scholarship
Summary of publications
Dr Escriu is co-author in several cancer biology peer-reviewed publications on stem-cell biology, prostate cancer and immunotherapy in Nature Cell Biology, Oncotarget, Oncogene – Nature and the Journal of National Cancer Institute (JNCI). His clinical peer-reviewed publications have focused on mutation-driven lung cancer and small cell lung cancer, with a recent review in novel therapies in early-stage lung cancer. His invited contributions include an editorial on a cancer biology paper on a novel epithelial growth factor receptor (EGFR) inhibitor.
Recognition
Prizes & awards
- Wesleyan RSM Young Trainee of the Year, Royal Society of Medicine; Second Prize (2013)
- NCRI Conference, National Cancer Research Institute; Poster prize (2013)
- Sylvia Lawler Prize, Royal Society of Medicine; Best non-clinical paper Oncology Section at the (2013)
Registration
Memberships of professional bodies & learned societies
- Fellow of the Royal College of Physicians
- National Cancer Research Institute (NCRI) advanced disease subgroup
- European Thoracic Oncology Platform (ETOP)
- European Organisation for Research and Treatment of Cancer (EORTC)
- European Society of Medical Oncology (ESMO)
Insights
Insights featuring Dr Carles Escriu
View all insights
Rapidly evolving lung cancer treatment and the importance of up-to-date oncology expertise in clinical negligence work
Lung cancer treatment advances and their relevance to clinical negligence claims, with insights into specialist oncology expertise from Dr Carles Escriu.
Contact Carles
Instruct Dr Escriu
Tell us about your case and our team will be in touch to discuss your instruction.
We handle your details in line with our Privacy & Cookie Policy.